26.06.2009 Boehringer Ingelheim receives positive recommendation from European scientific committee for a new once daily Mirapexin^® (pramipexole) formulation for the treatment of Parkinson’s disease For medical media, outside the US only 22.06.2009 Expedition to Mount Everest offers new insights into chronic disease For medical media, outside the US only 15.06.2009 Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease 14.06.2009 New investigational combination telmisartan and amlodipine shows effective and well-tolerated 24-hour blood pressure control in hypertensive patients at risk of cardiovascular events For medical media, outside the US only 10.06.2009 New data once more show high therapeutic benefits of Boehringer Ingelheim`s Mirapexin^®/Sifrol^® (pramipexole) once-daily extended release formulation, also in patients with advanced Parkinson`s disease For medical media, outside the US only 06.06.2009 New data from Boehringer Ingelheim`s ongoing linagliptin trial programme show promising safety and efficacy results For medical media, outside the US only 29.05.2009 Boehringer Ingelheim and DxS sign an agreement for a companion diagnostic to identify EGFR mutations in patients with lung cancer 27.05.2009 Boehringer Ingelheim and the World Stroke Organization announce partnership in the World Stroke Academy For medical media, outside the US only 15.05.2009 Boehringer Ingelheim to present new phase II clinical data on two lead oncology compounds at ASCO 2009 For medical media, outside the US only 13.05.2009 Boehringer Ingelheim and DeveloGen AG announce agreement in the field of diabetes, obesity and the metabolic syndrome